The Bone Marrow Niche in Waldenström's Macroglobulinemia
- 1 February 2011
- journal article
- review article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 11 (1), 118-120
- https://doi.org/10.3816/clml.2011.n.025
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Role of Proteasome Inhibition in Waldenström's MacroglobulinemiaClinical Lymphoma Myeloma and Leukemia, 2009
- Bone marrow microenvironment and the identification of new targets for myeloma therapyLeukemia, 2008
- The malignant clone and the bone-marrow environmentBest Practice & Research Clinical Haematology, 2007
- The stem cell niches in boneJCI Insight, 2006
- In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftmentNature, 2005
- Targeting Multiple Myeloma Cells and Their Bone Marrow MicroenvironmentAnnals of the New York Academy of Sciences, 2004
- Waldenström macroglobulinaemiaThe Lancet Oncology, 2003
- Novel therapies targeting the myeloma cell and its bone marrow microenvironmentSeminars in Oncology, 2001
- Integrin-Mediated Drug Resistance in Multiple MyelomaLeukemia & Lymphoma, 2000
- In Waldenstrom's macroglobulinemia the quantity of detectable circulating monoclonal B lymphocytes correlates with clinical courseBlood, 1983